Low molecular weight heparin: Difference between revisions
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
##[[NSTEMI]] | ##[[NSTEMI]] | ||
##[[STEMI]] | ##[[STEMI]] | ||
==Reversal== | |||
#Protamine | |||
##Does not completely reverse LMWHs | |||
##Carries significant anaphylaxis risk (0.2%); only use for major bleeding | |||
##Dosing | |||
###Enoxaparin: give 1mg IV for every 1mg of enoxaparin given in previous 8hr | |||
####If 8–12h since last enoxaparin dose give 0.5mg IV for every 1mg of enoxaparin given | |||
==See Also== | ==See Also== | ||
Revision as of 07:39, 21 October 2011
Background
- Similar mechanism of action as heparin but with predictable effect
- Advantages over unfractionated heparin:
- More reliable level of anticoagulation
- No need for monitoring w/ PTT
- Decreased incidence of HIT
- Can give as oupt
- Disadvantages compared to unfractionated heparin:
- Renally excreted; may accumulate in pts w/ renal impairment leading to bleeding
- Longer half-life
Dosing
- Renal impairment (Cr clearance <30)
- Use 50% of usual dose or use UFH instead
- Obesity
- Weight-based dosing safe up to 190kg (no data available thereafter)
Treatment
Reversal
- Protamine
- Does not completely reverse LMWHs
- Carries significant anaphylaxis risk (0.2%); only use for major bleeding
- Dosing
- Enoxaparin: give 1mg IV for every 1mg of enoxaparin given in previous 8hr
- If 8–12h since last enoxaparin dose give 0.5mg IV for every 1mg of enoxaparin given
- Enoxaparin: give 1mg IV for every 1mg of enoxaparin given in previous 8hr
See Also
Source
Tintinalli
